FYHTX
Price
$93.21
Change
-$0.00 (-0.00%)
Updated
Oct 22 closing price
PCRNX
Price
$13.32
Change
-$0.00 (-0.00%)
Updated
Oct 22 closing price
Ad is loading...

FYHTX vs PCRNX

Header iconFYHTX vs PCRNX Comparison
Open Charts FYHTX vs PCRNXBanner chart's image
Fidelity Commodity Strategy
Price$93.21
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
PIMCO Commodity Real Ret Strat I-3
Price$13.32
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FYHTX vs PCRNX Comparison Chart
Loading...
VS
FYHTX vs. PCRNX commentary
Oct 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FYHTX is a Hold and PCRNX is a Hold.

FUNDAMENTALS
Fundamentals
PCRNX has more cash in the bank: 3.67B vs. FYHTX (46.3M). FYHTX pays higher dividends than PCRNX: FYHTX (4.02) vs PCRNX (0.73). FYHTX was incepted earlier than PCRNX: FYHTX (7 years) vs PCRNX (6 years). FYHTX has a lower initial minimum investment than PCRNX: FYHTX (0) vs PCRNX (1000000). PCRNX annual gain was more profitable for investors over the last year : 1.72 vs. FYHTX (-0.14). PCRNX return over 5 years is better than : 46.30 vs. FYHTX (37.62).
FYHTXPCRNXFYHTX / PCRNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years6 years-
Gain YTD5.2025.146101%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets46.3M3.67B1%
Annual Yield % from dividends4.020.73549%
Returns for 1 year-0.141.72-8%
Returns for 3 years5.681.68339%
Returns for 5 years37.6246.3081%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EAEAX36.53N/A
N/A
Eaton Vance Tax-Managed Eq Aset Allc A
DIFIX12.43-0.01
-0.08%
MFS Diversified Income I
RYTIX207.25-0.49
-0.24%
Rydex Technology Inv
PGBGX46.11-0.24
-0.52%
Principal Blue Chip R5
LMGEX18.58-0.11
-0.59%
Franklin International Equity C